Vivos Therapeutics (VVOS) Q4 2024 Earnings

14NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-3.05
-2.17
-1.28
-0.4

Details

Expected EPS
-0.655
Actual EPS
-0.4
Surprise EPS
0.26
Surprise Percent
+38.93%

Description

Vivos Therapeutics (VVOS) has reported earnings of -0.4 per share for Q4 2024.

0 Comments

Share your thoughts